Safeguarding Biopharmaceuticals: The Critical Role of Viral Inactivation
In the world of biopharmaceutical manufacturing, patient safety is paramount. Biologics derived from human or animal sources carry an inherent risk of viral contamination, making viral inactivation a critical step in the production process. This essential safety measure ensures that therapeutic products—from blood plasma to monoclonal antibodies—are free from infectious viral...
0 Comentários 0 Compartilhamentos 3 Visualizações 0 Anterior